Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...

A new study represents a significant step forward in scientists' understanding of Alzheimer's disease. A team of investigators has examined the role of two proteins found in the brain and suggest the ...

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...

On Wednesday, Sen. Amy Klobuchar held an event highlighting legislation passed to support families who care for people living ...

A decade ago, researchers introduced a new model for studying Alzheimer's disease. Known as "Alzheimer's in a dish," the ...

(Reuters) -Cassava Sciences on Monday said its experimental Alzheimer's disease drug did not meet the main or secondary goals ...

Stay alert with list of early signs and symptoms of dementia that disrupts daily life and may be a symptom of Alzheimer’s or ...

Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.

Guided by the Alzheimer's Disease Prevention and Preparedness Task Force, California has taken “significant” action and made ...

November is National Alzheimer’s Awareness Month.The Alliance for Aging Research is using this month to raise awareness about ...

Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...

IGC Pharma, Inc. reported additional interim data from its clinical trial evaluating IGC-AD1 for agitation in Alzheimer’s.